Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)

NRG-HN001
NCT02135042
Cancer - Lip, Oral Cavity and Pharynx
Chaitali Nangia
Open
Treatment
5-FU, Cisplatin, Gemcitabine, Gemzar, Paclitaxel, Taxol
II/III
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.